Transmission and immunopathogenesis of FIV in cats as a model for HIV

被引:103
作者
Burkhard, MJ [1 ]
Dean, GA [1 ]
机构
[1] N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27606 USA
关键词
FIV; immunopathogenesis; HIV animal model; mucosal transmission; feline; FELINE IMMUNODEFICIENCY VIRUS; CHEMOKINE RECEPTOR CXCR4; LONG TERMINAL REPEAT; AP-1; BINDING-SITE; BLOOD MONONUCLEAR-CELLS; POLYMERASE-CHAIN-REACTION; CYTOTOXIC T-LYMPHOCYTES; IN-VIVO REPLICATION; FREE-RANGING LIONS; PRODUCTIVE INFECTION;
D O I
10.2174/1570162033352101
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The feline immunodeficiency virus (FIV) model provides a system to study lentivirus transmission, virus kinetics, pathogenesis, host responses, and immune dysfunction in a natural, out-bred host, under controlled conditions with specific-pathogen-free animals. The diversity of primary FIV strains can be exploited to mirror the range of disease manifestations associated with HIV infection. FIV is infectious via intravenous, intraperitoneal, intradermal, or subcutaneous injection as well as by atraumatic instillation onto the oral, vaginal, or rectal mucosa. Together, these features allow investigators to model specific aspects of HIV infection in a highly relevant and relatively inexpensive animal model. Well-developed areas of the FIV model include: (1) transmission of cell-associated as well as cell-free virus; (2) mucosal infectivity and immunopathogenesis; (3) vertical transmission; (4) acquired immunodeficiency including defects of the innate immune system; (5) thymic dysfunction; (6) neurotropism and neuropathogenesis; (7) host-virus interactions and the role of specific gene products; (8) efficacy of antiviral therapy; and (9) efficacy and immune correlates of experimental vaccines. This review will encompass areas specific to transmission and immunopathogenesis.
引用
收藏
页码:15 / 29
页数:15
相关论文
共 256 条
[41]   Suppressor T cells - they're back and critical for regulation of autoimmunity! [J].
Chatenoud, L ;
Salomon, B ;
Bluestone, JA .
IMMUNOLOGICAL REVIEWS, 2001, 182 :149-163
[42]   Feline immunodeficiency virus OrfA is distinct from other lentivirus transactivators [J].
Chatterji, U ;
de Parseval, A ;
Elder, JH .
JOURNAL OF VIROLOGY, 2002, 76 (19) :9624-9634
[43]   Anti-feline immunodeficiency virus (FIV) soluble factor(s) produced from antigen-stimulated feline CD8+ T lymphocytes suppresses FIV replication [J].
Choi, IS ;
Hokanson, R ;
Collisson, EW .
JOURNAL OF VIROLOGY, 2000, 74 (02) :676-683
[44]   Cell surface receptors, virus entry and tropism of primate lentiviruses [J].
Clapham, PR ;
McKnight, A .
JOURNAL OF GENERAL VIROLOGY, 2002, 83 :1809-1829
[45]   Tissue dynamics of CD8 lymphocytes that suppress viral replication in cats infected neonatally with feline immunodeficiency virus [J].
Crawford, PC ;
Papadi, GP ;
Levy, JK ;
Benson, NA ;
Mergia, A ;
Johnson, CM .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (06) :671-681
[46]   T-cell-rich B-cell lymphoma in the cat [J].
Day, MJ ;
Kyaw-Tanner, M ;
Silkstone, MA ;
Lucke, VM ;
Robinson, WF .
JOURNAL OF COMPARATIVE PATHOLOGY, 1999, 120 (02) :155-167
[47]   A multivariate statistical analysis to follow the course of disease after infection of cats with different strains of the feline immunodeficiency virus (FIV) [J].
de Monte, M ;
Nonnenmacher, H ;
Brignon, N ;
Ullmann, M ;
Martin, JP .
JOURNAL OF VIROLOGICAL METHODS, 2002, 103 (02) :157-170
[48]   Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial Rev activity [J].
de Parseval, A ;
Elder, JH .
JOURNAL OF VIROLOGY, 1999, 73 (01) :608-617
[49]   Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: Role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor [J].
de Parseval, A ;
Elder, JH .
JOURNAL OF VIROLOGY, 2001, 75 (10) :4528-4539
[50]   Differential cell tropism of feline immunodeficiency virus molecular clones in vivo [J].
Dean, GA ;
Himathongkham, S ;
Sparger, EE .
JOURNAL OF VIROLOGY, 1999, 73 (04) :2596-2603